Human Milk Oligosaccharides (HMO) Market Overview, Industry Top Manufactures, Size, Growth rate 2018 ? 2023

Human Milk Oligosaccharides (HMO) market report gives attention to market segmentation, market size, and forecast of 2018-2023 to help stakeholders in making a good decision for the future investments. Human Milk Oligosaccharides (HMO) industry report segmented into types, application, and regions with providing production, revenue, import/export. The Human Milk Oligosaccharides …

Extracorporeal Shock Wave Lithotripsy Machine Market Overview, Growth Forecast, Demand and Development Research Report to 2023

Global Extracorporeal Shock Wave Lithotripsy Machine Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Extracorporeal Shock Wave Lithotripsy Machine research report is a professional and in-depth …

Dynamic Blood Pressure Monitor Consumption Market Size 2023 – Global Industry Sales, Revenue, Price trends and more

According to Market Study Report, Dynamic Blood Pressure Monitor Market provides a comprehensive analysis of the Dynamic Blood Pressure Monitor market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities of global industry. This report also provides market landscape and market share information in …

Bilirubin Meters Consumption Market Global Briefing and Future Outlook 2018 to 2023

Market Study Report add Global Bilirubin Meters market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key …

Precision For Medicine buys ApoCell to expand biomarker capabilities

Precision for Medicine has announced the acquisition of ApoCell, a Houston-based next-generation lab that specializes in the identification and analysis of biomarkers. By acquiring ApoCell, its ApoStream® liquid biopsy technology and extensive tissue profiling expertise will be added to Precision’s strong portfolio of specialty laboratory and biomarker informatics services. The …

Roche invests an upfront of $125M to expand SQZ cell therapy program

SQZ Biotechnologies, a cell therapy conglomerate renowned for developing novel treatments for a wide range of diseases, has recently announced the expansion of its collaboration with Roche in cellular therapy. As per trusted sources, the expanded partnership with Roche’s cancer immunotherapy expertise would further SQZ’s innovation synergistic combination as well …

Roche unveils NGS AVENIO Tumor Tissue Analysis Kits for research use

The Basel headquartered healthcare company Roche Holding AG has globally launched three next-generation sequencing AVENIO Tumor Tissue Analysis Kits for use in oncology research. The new AVENIO Tumor Tissue Targeted Kit, Surveillance Kit and Expanded Kit help to detect all four mutation classes in solid tumors and compliment Roche’s NGS …

Eli Lilly launches Olumiant in India, forays into autoimmune segment

The U.S. based pharmaceutical firm Eli Lilly and Company has reportedly announced to have forayed in the autoimmune segment in India. As per trusted sources, the drug maker has launched a new once-daily oral therapy, named as Olumiant, to treat rheumatoid arthritis. Reportedly, OlumiantTM is an advanced and effective once-daily …

BMS, Compugen announce $12M immunotherapy clinical trial partnership

Bristol-Myers Squibb (BMS) and Compugen, the Israeli genomics-based drug and diagnostic discovery company have made an announcement recently informing that the two companies have entered into a clinical trial partnership. The companies will undertake trial to evaluate COM701 from Compugen with Opdivo, BMS’s PD-1 immune checkpoint inhibitor, in patients having …

Cannabis firm MedMen acquires PharmaCann worth USD 682 million

Los Angeles-based cannabis firm, MedMen Enterprises Inc. has recently announced its binding letter of intent to acquire the Illinois-based medical cannabis provider PharmaCann LLC for a valuation of USD 682 million. With thus takeover, MedMen will be expanding its reach with 79 licensed cannabis facilities amid growing operations in 12 …